Download Full Text (1.7 MB)
Policy Study 116
Center for the Study of American Business (CSAB), Washington University in St. Louis, St. Louis, MO 63130
With the cost of prescription medicines constantly rising, the government has been considering price controls. This report explains the R&D process from laboratory studies to FDA review to approval by the FDA. As an alternative to price controls, competition could be a way for helping to keep prices down.
Pharmaceutical Industry, Food and Drug Administration, Price Controls, Research and Development
Economics | Public Policy
Weidenbaum, Murray L., "Restraining Medicine Prices: Controls vs. Competition", Policy Study 116, 1993, doi:10.7936/K7K935Q7.
Murray Weidenbaum Publications, https://openscholarship.wustl.edu/mlw_papers/163.